Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

Glioblastoma, the most common malignant primary brain tumor in adults is a devastating diagnosis with an average survival of 14–16 months using the current standard of care treatment. The determination of treatment response and clinical decision making is based on the accuracy of radiographic assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Raymond Y., Neagu, Martha R., Reardon, David A., Wen, Patrick Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337341/
https://www.ncbi.nlm.nih.gov/pubmed/25755649
http://dx.doi.org/10.3389/fneur.2015.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337341/
https://www.ncbi.nlm.nih.gov/pubmed/25755649
http://dx.doi.org/10.3389/fneur.2015.00033

Ejemplares similares